drugset / Trial / NCT04296838

Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF

NCT04296838

NaSingle-groupOpen-labelTreatment

Summary

As a primary exploratory study, this study aims to evaluate the short-term effectiveness of intravitreal Conbercept injection in UME, and to explore the correlation between inflammatory factors like VEGF and the responsiveness to treatment.

Timeline

Start
2019-10-12
Primary completion
2020-04-12
Completion
2022-02-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic Other